Harvard Management as of June 30, 2022
Portfolio Holdings for Harvard Management
Harvard Management holds 45 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alphabet Cap Stk Cl A (GOOGL) | 30.4 | $263M | 121k | 2179.26 | |
| Meta Platforms Cl A (META) | 21.2 | $183M | 1.1M | 161.25 | |
| Scientific Games (LNW) | 14.6 | $126M | 2.7M | 46.99 | |
| Abcellera Biologics (ABCL) | 5.1 | $44M | 4.1M | 10.65 | |
| Eqrx | 2.9 | $25M | 5.3M | 4.69 | |
| Purecycle Technologies (PCT) | 2.1 | $19M | 2.5M | 7.42 | |
| Grab Holdings Class A Ord (GRAB) | 1.6 | $14M | 5.4M | 2.53 | |
| Revolution Medicines (RVMD) | 1.5 | $13M | 670k | 19.49 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 1.4 | $12M | 1.5M | 8.14 | |
| NVIDIA Corporation (NVDA) | 1.2 | $10M | 66k | 151.59 | |
| Meli Kaszek Pioneer Corp Class A Ord | 1.1 | $9.9M | 1.0M | 9.90 | |
| Qorvo (QRVO) | 1.1 | $9.9M | 105k | 94.32 | |
| Asml Holding N V N Y Registry Shs (ASML) | 1.1 | $9.6M | 20k | 475.87 | |
| Relay Therapeutics (RLAY) | 1.0 | $9.1M | 541k | 16.75 | |
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 1.0 | $8.8M | 107k | 81.75 | |
| Advanced Micro Devices (AMD) | 1.0 | $8.6M | 112k | 76.47 | |
| 10x Genomics Cl A Com (TXG) | 1.0 | $8.4M | 186k | 45.25 | |
| Lam Research Corporation | 0.9 | $8.2M | 19k | 426.17 | |
| Applied Materials (AMAT) | 0.9 | $8.0M | 88k | 90.99 | |
| Analog Devices (ADI) | 0.9 | $8.0M | 55k | 146.09 | |
| Intel Corporation (INTC) | 0.9 | $7.8M | 208k | 37.41 | |
| Kinnate Biopharma | 0.7 | $6.3M | 498k | 12.61 | |
| Micron Technology (MU) | 0.7 | $5.9M | 108k | 55.28 | |
| Pliant Therapeutics (PLRX) | 0.5 | $4.5M | 562k | 8.01 | |
| Nurix Therapeutics (NRIX) | 0.5 | $4.0M | 315k | 12.67 | |
| Tenaya Therapeutics (TNYA) | 0.4 | $3.8M | 673k | 5.63 | |
| Rocket Lab Usa | 0.4 | $3.8M | 1.0M | 3.79 | |
| Generation Bio | 0.4 | $3.3M | 510k | 6.56 | |
| Tango Therapeutics (TNGX) | 0.4 | $3.2M | 708k | 4.53 | |
| Affirm Hldgs Com Cl A (AFRM) | 0.4 | $3.1M | 174k | 18.06 | |
| Confluent Class A Com (CFLT) | 0.4 | $3.0M | 130k | 23.24 | |
| Sana Biotechnology (SANA) | 0.3 | $3.0M | 469k | 6.43 | |
| Surrozen | 0.3 | $2.4M | 827k | 2.94 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $2.0M | 411k | 4.90 | |
| Praxis Precision Medicines I | 0.2 | $1.9M | 779k | 2.45 | |
| Purecycle Technologies *w Exp 03/17/202 (PCTTW) | 0.2 | $1.9M | 714k | 2.65 | |
| Decibel Therapeutics | 0.2 | $1.4M | 329k | 4.21 | |
| Pardes Biosciences | 0.1 | $1.2M | 400k | 3.07 | |
| Xilio Therapeutics (XLO) | 0.1 | $1.2M | 416k | 2.92 | |
| Pacific Biosciences of California (PACB) | 0.1 | $1.0M | 229k | 4.42 | |
| Vigil Neuroscience (VIGL) | 0.1 | $747k | 290k | 2.58 | |
| Dyne Therapeutics (DYN) | 0.1 | $737k | 107k | 6.87 | |
| Seres Therapeutics | 0.1 | $452k | 132k | 3.43 | |
| Gemini Therapeutics | 0.0 | $423k | 250k | 1.69 | |
| Magenta Therapeutics | 0.0 | $399k | 333k | 1.20 |
